Evidence map›Paper›PMID 32694259›Full record

ArticleCerebrovascular diseases (Basel, Switzerland)2020

Effects of White Matter Hyperintensities on 90-Day Functional Outcome after Large Vessel and Non-Large Vessel Stroke.

Christoph Johannes Griessenauer, David McPherson, Andrea Berger, Ping Cuiper, Nelson Sofoluke, Matthew D Adams, Saran Kunaprayoon, Ramin Zand, Jiang Li, Vida Abedi and 8 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cerebrovascular diseases (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Christoph Johannes GriessenauerDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA, christoph.griessenauer@gmail.com.
David McPhersonGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Andrea BergerBiostatistics Core, Geisinger, Danville, Pennsylvania, USA.
Ping CuiperBiostatistics Core, Geisinger, Danville, Pennsylvania, USA.
Nelson SofolukeDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
Matthew D AdamsGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Saran KunaprayoonGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Ramin ZandDepartment of Neurology, Geisinger, Danville, Pennsylvania, USA.
Jiang LiDepartment of Molecular and Functional Genomics, Geisinger, Danville, Pennsylvania, USA.
Vida AbediDepartment of Molecular and Functional Genomics, Geisinger, Danville, Pennsylvania, USA.
Oded GorenDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
Clemens M SchirmerDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
Kathleen DonahueDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marco NardinDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Anne-Karin GieseDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Markus D SchirmerDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Natalia S RostDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Philipp HendrixDepartment of Neurosurgery, Geisinger, Danville, Pennsylvania, USA.
Geisinger Medical Center · USHarvard University · USGeisinger Commonwealth School of Medicine · US

Funding

MRI-GENetics Interface Exploration_MRI-GENIE_StudyR01NS086905 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROST, NATALIA S · 2015 to 2019
$3.3M
NINDS NIH HHS R01 NS086905
6 · The paper itself

Abstract

introductionWhite matter hyperintensity (WMH) burden is a critically important cerebrovascular phenotype related to the diagnosis and prognosis of acute ischemic stroke. The effect of WMH burden on functional outcome in large vessel occlusion (LVO) stroke has only been sparsely assessed, and direct LVO and non-LVO comparisons are currently lacking. MATERIAL AND

methodsWe reviewed acute ischemic stroke patients admitted between 2009 and 2017 at a large healthcare system in the USA. Patients with LVO were identified and clinical characteristics, including 90-day functional outcomes, were assessed. Clinical brain MRIs obtained at the time of the stroke underwent quantification of WMH using a fully automated algorithm. The pipeline incorporated automated brain extraction, intensity normalization, and WMH segmentation.

resultsA total of 1,601 acute ischemic strokes with documented 90-day mRS were identified, including 353 (22%) with LVO. Among those strokes, WMH volume was available in 1,285 (80.3%) who had a brain MRI suitable for WMH quantification. Increasing WMH volume from 0 to 4 mL, age, female gender, a number of stroke risk factors, presence of LVO, and higher NIHSS at presentation all decreased the odds for a favorable outcome. Increasing WMH above 4 mL, however, was not associated with decreasing odds of favorable outcome. While WMH volume was associated with functional outcome in non-LVO stroke (p = 0.0009), this association between WMH and functional status was not statistically significant in the complete case multivariable model of LVO stroke (p = 0.0637).

conclusionThe burden of WMH has effects on 90-day functional outcome after LVO and non-LVO strokes. Particularly, increases from no measurable WMH to 4 mL of WMH correlate strongly with the outcome. Whether this relationship of increasing WMH to worse outcome is more pronounced in non-LVO than LVO strokes deserves additional investigation.

Indexed as

Magnetic Resonance ImagingStroke RehabilitationAgedAged, 80 and overBrain IschemiaDisability EvaluationFemaleHumansLeukoencephalopathiesMaleMiddle AgedPredictive Value of TestsRecovery of FunctionRegistriesRetrospective StudiesRisk FactorsHyperintensityLarge vessel occlusionOutcomeStrokeWhite matter

Identifiers

PMID32694259
PMCPMC7501232
OpenAlexW3043980079

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.